CTNNB1 |
P35222
|
catenin beta 1
|
|
1.00 |
0.303 |
0.885 |
CREBBP |
Q92793
|
CREB binding protein
|
|
1.00 |
0.428 |
0.808 |
FANCA |
O15360
|
FA complementation group A
|
|
1.6E-68 |
0.505 |
0.731 |
MITF |
O75030
|
melanocyte inducing transcription factor
|
|
0.98 |
0.499 |
0.808 |
FTO |
Q9C0B1
|
FTO alpha-ketoglutarate dependent dioxygenase
|
|
8.4E-08 |
0.486 |
0.885 |
CYP21A2 |
P08686
|
cytochrome P450 family 21 subfamily A member 2
|
|
2.6E-04 |
0.525 |
0.769 |
WDPCP |
O95876
|
WD repeat containing planar cell polarity effector
|
|
1.1E-10 |
0.576 |
0.769 |
CDKN2A |
P42771 Q8N726
|
cyclin dependent kinase inhibitor 2A
|
|
0.39 |
0.300 |
0.885 |
CDH1 |
P12830
|
cadherin 1
|
|
0.15 |
0.401 |
0.808 |
SYNE2 |
Q8WXH0
|
spectrin repeat containing nuclear envelope protein 2
|
|
1.7E-25 |
0.623 |
0.692 |
IDH1 |
O75874
|
isocitrate dehydrogenase (NADP(+)) 1
|
|
2.6E-12 |
0.424 |
0.808 |
CDKAL1 |
Q5VV42
|
CDK5 regulatory subunit associated protein 1 like 1
|
|
1.6E-02 |
0.617 |
0.615 |
STN1 |
Q9H668
|
STN1 subunit of CST complex
|
|
2.3E-10 |
0.604 |
0.769 |
C11orf65 |
Q8NCR3
|
chromosome 11 open reading frame 65
|
|
2.0E-14 |
0.670 |
0.462 |
OCA2 |
Q04671
|
OCA2 melanosomal transmembrane protein
|
|
2.9E-13 |
0.539 |
0.808 |
PIGU |
Q9H490
|
phosphatidylinositol glycan anchor biosynthesis class U
|
|
1.9E-05 |
0.670 |
0.462 |
STK19 |
P49842
|
serine/threonine kinase 19
|
|
6.7E-09 |
0.691 |
0.500 |
POLH |
Q9Y253
|
DNA polymerase eta
|
|
3.5E-09 |
0.663 |
0.462 |
LINC01505 |
|
long intergenic non-protein coding RNA 1505
|
|
|
0.821 |
0.192 |
FMN1 |
Q68DA7
|
formin 1
|
|
3.6E-18 |
0.686 |
0.423 |
CYP1B1-AS1 |
|
CYP1B1 antisense RNA 1
|
|
|
0.769 |
0.154 |
CASC11 |
|
cancer susceptibility 11
|
|
|
0.641 |
0.577 |
SF3B2 |
Q13435
|
splicing factor 3b subunit 2
|
|
1.00 |
0.780 |
0.308 |
LINC-PINT |
|
long intergenic non-protein coding RNA, p53 induced transcript
|
|
|
0.663 |
0.577 |
TASOR2 |
Q5VWN6
|
transcription activation suppressor family member 2
|
|
0.31 |
0.861 |
0.077 |